Novartis profit tops expectations
Swiss drugmaker Novartis beat second-quarter sales and profit expectations, while keeping its 2021 guidance unchanged, as disruption from the coronavirus pandemic waned.
Subscribe to:
Post Comments (Atom)
Comments
Post a Comment
Leave a comment. Thanks!
Comentarios de Facebook